Wedge Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Wedge Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-98,602	Closed	-$512K	–	599
2018 Q2	$512K	Hold	98,602	–	–	0.01%	458
2018 Q1	$540K	Buy	98,602 +37,102	+60%	+$261K	0.01%	443
2017 Q4	$501K	Hold	61,500	–	–	﹤0.01%	456
2017 Q3	$644K	Sell	61,500 -9,000	-13%	-$99.9K	0.01%	422
2017 Q2	$778K	Sell	70,500 -13,400	-16%	-$125K	0.01%	379
2017 Q1	$702K	Hold	83,900	–	–	0.01%	380
2016 Q4	$582K	Hold	83,900	–	–	0.01%	413
2016 Q3	$427K	Buy	+83,900	New	+$501K	﹤0.01%	464

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wedge Capital Management's ENZ Position: Q3 2018 in Review

Wedge Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2018, closing a stake of 98,602 shares — an estimated $512K sold.

Wedge Capital Management first reported a position in ENZ in Q3 2016 and held it in 8 quarters. The position peaked at $778K in Q2 2017. 101 funds tracked by Wall St. Rank hold ENZ as of Q3 2018.

Wedge Capital Management reported no remaining Enzo Biochem, Inc. position as of Q3 2018 after selling out during the quarter.
Wedge Capital Management sold 98,602 Enzo Biochem, Inc. shares in Q3 2018, an estimated $512K.
Wedge Capital Management first reported a position in Enzo Biochem, Inc. in Q3 2016 and held it in 8 quarters.
Wedge Capital Management's Enzo Biochem, Inc. position peaked at $778K in Q2 2017.
101 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2018.

Based on Wedge Capital Management's 13F filing for Q3 2018, filed 1 Nov 2018.